imipramine has been researched along with Blindness in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VINAROVA, M | 1 |
| NAHUNEK, K | 1 |
| VENCOVSKY, E | 1 |
| BAST ECKY, J | 1 |
| HADLIK, J | 1 |
1 other study available for imipramine and Blindness
| Article | Year |
|---|---|
[Blind comparison of clinical effects of Imipramine and Propazepine].
Topics: Antidepressive Agents; Blindness; Humans; Imipramine; Visually Impaired Persons | 1962 |